skip to main content
Idioma:
Refinado por: tipo de recurso: Imagens remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Additional file 1 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Additional file 1 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Material Type:
Imagem 		Adicionar ao Meu Espaço

Additional file 1 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes

Fang, Qianhua ; Shi, Juan ; Zhang, Jia ; Peng, Ying ; Liu, Cong ; Wei, Xing ; Hu, Zhuomeng ; Sun, Lin ; Hong, Jie ; Gu, Weiqiong ; Wang, Weiqing ; Zhang, Yifei

figshare 2023

Texto completo disponível

Citações Citado por
2
Additional file 3 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Additional file 3 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Material Type:
Imagem 		Adicionar ao Meu Espaço

Additional file 3 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes

Fang, Qianhua ; Shi, Juan ; Zhang, Jia ; Peng, Ying ; Liu, Cong ; Wei, Xing ; Hu, Zhuomeng ; Sun, Lin ; Hong, Jie ; Gu, Weiqiong ; Wang, Weiqing ; Zhang, Yifei

figshare 2023

Texto completo disponível

Citações Citado por
3
Additional file 2 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Additional file 2 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes
Material Type:
Imagem 		Adicionar ao Meu Espaço

Additional file 2 of Visit-to-visit HbA1c variability is associated with aortic stiffness progression in participants with type 2 diabetes

Fang, Qianhua ; Shi, Juan ; Zhang, Jia ; Peng, Ying ; Liu, Cong ; Wei, Xing ; Hu, Zhuomeng ; Sun, Lin ; Hong, Jie ; Gu, Weiqiong ; Wang, Weiqing ; Zhang, Yifei

figshare 2023

Texto completo disponível

Citações Citado por
4
sj-tif-3-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tif-3-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tif-3-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
5
sj-tif-4-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tif-4-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tif-4-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
6
sj-tiff-1-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tiff-1-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tiff-1-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
7
sj-tif-2-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tif-2-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tif-2-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
8
sj-tiff-6-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tiff-6-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tiff-6-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
9
sj-tiff-7-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tiff-7-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tiff-7-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por
10
sj-tiff-5-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
sj-tiff-5-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tiff-5-tam-10.1177_17588359221118020 – Supplemental material for Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)

Dai, Yu-Hong ; Yu, Xiong-Jie ; Xu, Hui-Ting ; Zhuang, Liang ; Zhang, Ming-Sheng ; Zou, Yan-Mei ; Fu, Qiang ; Qiu, Hong ; Yuan, Xiang-Lin

SAGE Journals 2022

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.